ArticleBiotechnology for biofuels and bioproducts2025
Development of a β-glucosidase improved for glucose retroinhibition for cellulosic ethanol production: an integrated bioinformatics and genetic engineering approach.
Article in Biotechnology for biofuels and bioproducts, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Buffalo rumen microbial cellulase as a candidate enzyme for hydrolysis of rice straw into glucose: A preliminary study.Open veterinary journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe global energy crisis, driven by economic growth and the increasing demand for energy, highlights the urgency of searching for alternative energy sources to mitigate environmental pollution and climate change. β-Glucosidases act in the final step of the enzymatic hydrolysis of cellulose, cleaving the β-1,4-glycosidic bonds in cellobiose to produce second-generation ethanol. However, these enzymes are easily inhibited by glucose, their final product, which limits the production of this biofuel. Genetic engineering combined with bioinformatics tools can improve key enzymatic characteristics, such as catalytic activity and glucose tolerance, in a more precise, faster, and cost-effective manner compared to traditional methods. In this work, a variant of a β-glucosidase from the GH1 family, isolated from the microbial community of Amazonian soil (Brazil), with enhanced catalytic activity and improved for glucose retroinhibition, was developed.
resultsBioinformatics analyses suggested the substitution of tryptophan at position 404 with leucine. The produced variant (W404L) was expressed in Escherichia coli and showed activity 3.2 times higher in the presence of glucose than the non-mutated control. Moreover, the partially purified mutated variant of β-glucosidase exhibited a 26-fold increase in catalytic activity compared to the original form of the enzyme. The results confirmed that the mutation proposed by computational analyses had a significant impact on enzyme catalytic activity and glucose retroinhibition.
conclusionsThis new variant may become a promising alternative to reduce the costs of enzyme cocktails used in the hydrolysis of lignocellulosic biomass used as a raw material in the production of second-generation ethanol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.